IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 124 filers reported holding IMMUNOVANT INC in Q3 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,185,216 | +692.0% | 317,406 | +291.4% | 0.29% | +775.8% |
| Q2 2023 | $1,538,467 | -41.7% | 81,100 | -52.3% | 0.03% | -38.9% |
| Q1 2023 | $2,638,251 | -15.7% | 170,100 | -3.6% | 0.05% | -25.0% |
| Q4 2022 | $3,130,887 | +294.8% | 176,388 | +24.1% | 0.07% | +260.0% |
| Q3 2022 | $793,000 | +183.2% | 142,135 | +341.0% | 0.02% | +150.0% |
| Q3 2021 | $280,000 | -77.3% | 32,233 | -72.4% | 0.01% | -79.5% |
| Q2 2021 | $1,234,000 | -6.5% | 116,759 | +308.7% | 0.04% | -20.4% |
| Q4 2020 | $1,320,000 | -3.9% | 28,568 | -26.8% | 0.05% | -41.0% |
| Q3 2020 | $1,374,000 | +58.8% | 39,032 | +9.9% | 0.08% | +40.7% |
| Q2 2020 | $865,000 | -53.5% | 35,507 | -70.3% | 0.06% | -61.7% |
| Q1 2020 | $1,862,000 | +38.5% | 119,604 | +41.3% | 0.15% | +31.6% |
| Q4 2019 | $1,344,000 | – | 84,663 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |